Lung Cancer
News
Hepatitis screening now for all patients with cancer on therapy
All patients with cancer who are candidates for systemic therapy should be screened for hepatitis B, says the American Society of Clinical...
News
OK to treat many cancer patients despite pandemic, says ESMO
ESMO recommends against stopping or delaying cancer treatment that can impact survival.
Conference Coverage
Higher death rate seen in cancer patients with nosocomial COVID-19
All-cause mortality was higher in cancer patients with hospital-acquired COVID-19 than in those with community-acquired COVID-19.
News
Heavy toll from ongoing cancer referral delays
News
USPSTF: Earlier lung cancer screening can double eligibility
New proposals to start screening at age 50 rather than 55, and after 20 rather than 30 pack-years of smoking, could benefit Black and female...
News
Could being active reduce cancer death risk from alcohol?
Regular physical activity may reduce the risk of death from alcohol-related cancers.
Conference Coverage
Personalized cancer vaccine may enhance checkpoint inhibitor activity
Conference Recap
Highlights in Non–Small Cell Lung Cancer From ASCO 2020
Dr. Mark Kris reports on key studies in NSCLC from ASCO 2020, including the practice-changing ADAURA trial, results on an antibody‒...
Conference Coverage
Immunotherapy combo improves ORR, PFS in PD-L1+ NSCLC
Adding tiragolumab to atezolizumab led to “clinically meaningful” improvements in patients with PD-L1–positive non–small cell lung cancer.
Conference Coverage
No OS benefit with gefitinib vs. chemo for EGFR+ NSCLC
Adjuvant gefitinib improved disease-free survival, but not overall survival, when compared with standard chemotherapy.